Quinlog, Raycel A.
HRN: 21-45-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2022
CEFTRIAXONE 1G (VIAL)
06/13/2022
06/20/2022
IV
2grams
OD
UTI; Molar Pregnancy
Waiting Final Action
Indication: EmpiricEmpirical De-escalation Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes